Sakamato et al., in their study on dedifferentiated liposarcomas, showed that four out of 19 patients had an H-RAS mutation, and 15 well-differentiated liposarcoma patients had no H-RAS mutation [55]. This evidence concerns the gene HRAS and liposarcoma.